Globus Medical Inc [GMED] stock is trading at $59.58, up 1.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GMED shares have gain 5.32% over the last week, with a monthly amount glided 4.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Globus Medical Inc [NYSE: GMED] stock has seen the most recent analyst activity on May 27, 2025, when BTIG Research downgraded its rating to a Neutral. Previously, BofA Securities upgraded its rating to Neutral on January 10, 2025, and kept the price target unchanged to $97. On December 02, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $100 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $78 on August 07, 2024. Piper Sandler upgraded its rating to a Overweight and raised its price target to $80 on May 20, 2024. BTIG Research upgraded its rating to Buy for this stock on March 18, 2024, but kept the price target unchanged to $60. In a note dated October 20, 2023, ROTH MKM initiated an Buy rating and provided a target price of $75 on this stock.
Globus Medical Inc [GMED] stock has fluctuated between $51.79 and $94.93 over the past year. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Globus Medical Inc [NYSE: GMED] shares were valued at $59.58 at the most recent close of the market. An investor can expect a potential return of 47.7% based on the average GMED price forecast.
Analyzing the GMED fundamentals
Globus Medical Inc [NYSE:GMED] reported sales of 2.63B for the trailing twelve months, which represents a growth of 18.37%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.11%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.09 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 58.79 points at the first support level, and at 58.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.08, and for the 2nd resistance point, it is at 60.59.
Ratios To Look Out For
For context, Globus Medical Inc’s Current Ratio is 4.07. As well, the Quick Ratio is 2.26, while the Cash Ratio is 0.54. Considering the valuation of this stock, the price to sales ratio is 3.06, the price to book ratio is 1.87 and price to earnings (TTM) ratio is 22.99.
Transactions by insiders
Recent insider trading involved RHOADS ANN D, Director, that happened on Sep 15 ’25 when 10000.0 shares were sold. Director, RHOADS ANN D completed a deal on Sep 15 ’25 to buy 10000.0 shares. Meanwhile, Director RHOADS ANN D sold 7500.0 shares on Feb 28 ’25.
